Joseph Swedish, CEO at Anthem, talks about his company's on-going deal to buy Cigna, the outlook for Anthem in Obamacare exchanges, and working toward affordable drug prices. » Read More
The American consumer is a major theme Thursday, as chain stores report their monthly sales.
Some of Goldman Sachs' most important stock picks last quarter have fallen flat. But several of its so-called conviction-buy recommendations from last year have outperformed stock-market benchmarks many times over. Some may even rise further, according to Goldman's analysts.
What follows is a look at stocks in the S&P 500 displaying unusual volume in today's trading session.
Stocks ended lower Wednesday as energy and financials dragged. Consumer discretionary and industrials were among the best performers.
Stocks ended mostly higher after a late rally Tuesday as banks and materials rebounded. But tech stocks remained under pressure.
Stocks staged a late rally Tuesday as energy stocks made a comeback. But tech stocks fell after several downgrades.
Trading has been bullish in WellPoint Health Networks and Health Net since early Friday morning, as the rumor mill goes into overdrive. Both health insurers are up in an ugly tape, though the option activity is much greater in WellPoint.
Two fund managers told CNBC Friday that they lost less than 1 percent of net asset value, despite Thursday's 347-point plunge by the Dow Jones Industrial Average.
Stocks staged one of the most dramatic selloffs in market history Thursday as what may have been a trader error exacerbated losses in a market already jittery about the European debt crisis. The Dow ended down about 350 points and the VIX was above 34.
What follows is a roundup of corporate earnings reports for Thursday, May 6.
Stocks pared their losses on Wednesday after a weak open, but the market remained skittish after Moody's put Portugal's debt rating on review. Dan Denbow, co-portfolio manager of USAA Precious Metals & Minerals Fund and Jim Meyer, chief investment officer and co-founder of Tower Bridge Advisors shared their insights.
Markets could see a correction in the June to July time frame, said Tobias Levkovich, chief U.S. equity strategist at Citi. He shared his market outlook with investors.
The Dow erased nearly all of its gains Monday, dragged down by the financial sector amid worries about financial reform. Caterpillar led the Dow's gainers, up more than 4 percent.
The Dow remained higher in mid-afternoon Monday amid a flurry of new M&A activity and an earnings beat from Caterpillar. But there was some weakness in the energy, banking and health-care sectors, which dragged on the S&P and Nasdaq.
Stocks ended higher Tuesday, led by energy and financials. But IBM and Goldman Sachs declined.
American corporations cut back on a number executive perks in 2009, in response to the economic downturn. One benefit, however, remained a top priority: personal security for chief executives.
The S&P Health Care Index has been seeing a boost from the health care bill. Will the stocks continue to get a lift from the new legislation—and how should you play the sector? Ipsita Smolinski, president and health care analyst at Capitol Street, and Carl McDonald, health care analyst and managed care analyst at Oppenheimer, discussed their views.
House Democrats are pushing to pass the health care bill as Pres. Obama seeks to rally recalcitrant congresspeople. Which stocks and sectors actually stand to benefit from the bill? Les Funtleyder, health care strategist at Miller Tabak, Jason Gurda, managed care analyst at Leerink Swann and Ralph Giacobbe, analyst at Credit Suisse First Boston offered their insights and investment recommendations.
February chain stores' sales and weekly jobless claims data, due ahead of the opening bell on Thursday, will likely feel the chill from winter storms.
Stocks logged a solid 3-percent gain for February but the momentum faded in the past week as confidence in the recovery began to falter. Financials and health-care stocks were among the best performers; consumer-focused stocks fell out of favor.